VarmX is involved in the development of therapeutics that have the potential to bypass synthetic inhibitors of coagulation factors IIa and XIa.
VarmX is involved in the development of therapeutics that have the potential to bypass synthetic inhibitors of coagulation factors IIa and XIa.